IFNG and diffuse large B-cell lymphoma: PARP9, also known as B-aggressive lymphoma-1 (BAL1), was identified as a risk-related gene product in aggressive diffuse large B-cell lymphoma (DLBCL) and associated with interferon-gamma (IFNγ) gene expression and signalling.